J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pentikainen, P.
Right arrow Articles by Rogers, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pentikainen, P.
Right arrow Articles by Rogers, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Articles

Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humans

PJ Pentikainen, M Saraheimo, JI Schwartz, RD Amin, MS Schwartz, F Brunner-Ferber, and JD Rogers

Twelve healthy male volunteers received single market-image 40-mg oral doses of lovastatin and simvastatin (both lactone prodrugs), or pravastatin (a beta-hydroxyacid) at 1 week intervals in a three-way crossover study to quantify HMG-CoA reductase inhibitors in plasma. Multiple plasma samples were collected up to 24 hours after the dose and assayed for active and total HMG-CoA reductase inhibitors. After equal oral doses, higher plasma concentrations of HMG-CoA reductase inhibitory activity after pravastatin than after either lovastatin of simvastatin (2-3 fold greater area under the concentration-time curve) suggest a greater potential availability of pravastatin-related inhibitory activity to peripheral tissues.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
S. Jerwood and J. Cohen
Unexpected antimicrobial effect of statins
J. Antimicrob. Chemother., February 1, 2008; 61(2): 362 - 364.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
A. Yilmaz, C. Reiss, A. Weng, I. Cicha, C. Stumpf, A. Steinkasserer, W. G. Daniel, and C. D. Garlichs
Differential effects of statins on relevant functions of human monocyte-derived dendritic cells
J. Leukoc. Biol., March 1, 2006; 79(3): 529 - 538.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
P. Gargalovic and L. Dory
Cellular apoptosis is associated with increased caveolin-1 expression in macrophages
J. Lipid Res., September 1, 2003; 44(9): 1622 - 1632.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
K. K. Koh
Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability
Cardiovasc Res, September 1, 2000; 47(4): 648 - 657.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American College of Clinical Pharmacology